Potently immunosuppressive 5-fluorouracil-resistant mesenchymal stromal cells completely remit an experimental autoimmune disease

Journal of Immunology

Volumn 188, Issue 5, 2012, Pages 2207-2217

  Oh, Ding Yuan ^a,b   Cui, Peng ^a   Hosseini, Hamid ^a   Mosse, Jennifer ^b   Toh, Ban Hock ^a   Chan, James ^a  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY OF BALLARAT   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CD45 ANTIGEN; FLUOROURACIL; HEME OXYGENASE 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; NITRIC OXIDE; PROSTAGLANDIN E2;

ADIPOCYTE; ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL DIFFERENTIATION; CELL INFILTRATION; CELL ISOLATION; CELL PROLIFERATION; CELL SIZE; COLONY FORMING UNIT; CONTROLLED STUDY; DEMYELINATION; DISEASE SEVERITY; DRUG POTENCY; DRUG RESISTANCE; FEMALE; FIBROBLAST; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; IN VIVO STUDY; MESENCHYMAL STROMA CELL; MOUSE; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; REMISSION; SPLEEN CELL;

ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; COCULTURE TECHNIQUES; DISEASE MODELS, ANIMAL; DOWN-REGULATION; DRUG RESISTANCE; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; FLUOROURACIL; IMMUNOSUPPRESSIVE AGENTS; LYMPHOCYTE ACTIVATION; MESODERM; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; STROMAL CELLS;

EID: 84857484410     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1101040     Document Type: Article

References (58)

1. Friedenstein, A. J., J. F. Gorskaja, and N. N. Kulagina. 1976. Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp. Hematol. 4: 267-274.
2. Chamberlain, G., J. Fox, B. Ashton, and J. Middleton. 2007. Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells 25: 2739-2749. (Pubitemid 350127858)
3. Tolar, J., K. Le Blanc, A. Keating, and B. R. Blazar. 2010. Concise review: hitting the right spot with mesenchymal stromal cells. Stem Cells 28: 1446-1455.
4. Longley, D. B., D. P. Harkin, and P. G. Johnston. 2003. 5-fluorouracil: mechanisms of action and clinical strategies. Nat. Rev. Cancer 3: 330-338. (Pubitemid 37328853)
5. Wang, Z., J. Song, R. S. Taichman, and P. H. Krebsbach. 2006. Ablation of proliferating marrow with 5-fluorouracil allows partial purification of mesenchymal stem cells. Stem Cells 24: 1573-1582. (Pubitemid 44464675)
6. Falla, N., J. Van Vlasselaer, B. Bierkens, G. Borremans, Schoeters, and U. Van Gorp. 1993. Characterization of a 5-fluorouracil-enriched osteoprogenitor population of the murine bone marrow. Blood 82: 3580-3591. (Pubitemid 24006038)
7. Uccelli, A., L. Moretta, and V. Pistoia. 2008. Mesenchymal stem cells in health and disease. Nat. Rev. Immunol. 8: 726-736.
8. Di Nicola, M., C. Carlo-Stella, M. Magni, M. Milanesi, P. D. Longoni, P. Matteucci, S. Grisanti, and A. M. Gianni. 2002. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 99: 3838-3843. (Pubitemid 34534559)
9. Glennie, S., I. Soeiro, P. J. Dyson, E. W. Lam, and F. Dazzi. 2005. Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells. Blood 105: 2821-2827. (Pubitemid 40446275)
10. Yang, S. H., M. J. Park, I. H. Yoon, S. Y. Kim, S. H. Hong, J. Y. Shin, H. Y. Nam, Y. H. Kim, B. Kim, and C. G. Park. 2009. Soluble mediators from mesenchymal stem cells suppress T cell proliferation by inducing IL-10. Exp. Mol. Med. 41: 315-324.
11. Tyndall, A., and A. Uccelli. 2009. Multipotent mesenchymal stromal cells for autoimmune diseases: teaching new dogs old tricks. Bone Marrow Transplant. 43: 821-828.
12. Uccelli, A., and D. J. Prockop. 2010. Why should mesenchymal stem cells (MSCs) cure autoimmune diseases? Curr. Opin. Immunol. 22: 768-774.
13. Zappia, E., S. Casazza, E. Pedemonte, F. Benvenuto, I. Bonanni, E. Gerdoni, D. Giunti, A. Ceravolo, F. Cazzanti, F. Frassoni, et al. 2005. Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood 106: 1755-1761. (Pubitemid 41208591)
14. Gerdoni, E., B. Gallo, S. Casazza, S. Musio, I. Bonanni, E. Pedemonte, R. Mantegazza, F. Frassoni, G. Mancardi, R. Pedotti, and A. Uccelli. 2007. Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis. Ann. Neurol. 61: 219-227. (Pubitemid 46557346)
15. Kassis, I., N. Grigoriadis, B. Gowda-Kurkalli, R. Mizrachi-Kol, T. Ben-Hur, S. Slavin, O. Abramsky, and D. Karussis. 2008. Neuroprotection and immunomodulation with mesenchymal stem cells in chronic experimental autoimmune encephalomyelitis. Arch. Neurol. 65: 753-761. (Pubitemid 351831453)
16. Katsara, O., L. G. Mahaira, E. G. Iliopoulou, A. Moustaki, A. Antsaklis, D. Loutradis, K. Stefanidis, C. N. Baxevanis, M. Papamichail, and S. A. Perez. 2011. Effects of donor age, gender, and in vitro cellular aging on the phenotypic, functional, and molecular characteristics of mouse bone marrow-derived mesenchymal stem cells. Stem Cells Dev. 20: 1549-1561.
17. Phinney, D. G. 2008. Isolation of mesenchymal stem cells from murine bone marrow by immunodepletion. Methods Mol. Biol. 449: 171-186.
18. Chan, J., E. J. Ban, K. H. Chun, S. Wang, B. T. Bäckström, C. C. Bernard, B. H. Toh, and F. Alderuccio. 2008. Transplantation of bone marrow transduced to express self-antigen establishes deletional tolerance and permanently remits autoimmune disease. J. Immunol. 181: 7571-7580.
19. Lee, H. J., Y. I. Jeong, T. H. Lee, I. D. Jung, J. S. Lee, C. M. Lee, J. I. Kim, H. Joo, J. D. Lee, and Y. M. Park. 2007. Rosmarinic acid inhibits indoleamine 2,3-dioxygenase expression in murine dendritic cells. Biochem. Pharmacol. 73: 1412-1421. (Pubitemid 46463948)
20. Bianco, P., P. G. Robey, and P. J. Simmons. 2008. Mesenchymal stem cells: revisiting history, concepts, and assays. Cell Stem Cell 2: 313-319. (Pubitemid 351467394)
21. Pittenger, M. F., A. M. Mackay, S. C. Beck, R. K. Jaiswal, R. Douglas, J. D. Mosca, M. A. Moorman, D. W. Simonetti, S. Craig, and D. R. Marshak. 1999. Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147. (Pubitemid 29282067)
22. Bianco, P., and P. Gehron Robey. 2000. Marrow stromal stem cells. J. Clin. Invest. 105: 1663-1668. (Pubitemid 30421745)
23. Peister, A., J. A. Mellad, B. L. Larson, B. M. Hall, L. F. Gibson, and D. J. Prockop. 2004. Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential. Blood 103: 1662-1668. (Pubitemid 38268957)
24. Phinney, D. G., G. Kopen, R. L. Isaacson, and D. J. Prockop. 1999. Plastic adherent stromal cells from the bone marrow of commonly used strains of inbred mice: variations in yield, growth, and differentiation. J. Cell. Biochem. 72: 570-585. (Pubitemid 29088308)
25. Anjos-Afonso, F. and D. Bonnet. 2008. Isolation, culture, and differentiation potential of mouse marrow stromal cells. Curr. Protoc. Stem Cell Biol. Oct; Chapter 2:Unit 2B.3.
26. Mougiakakos, D., R. Jitschin, C. C. Johansson, R. Okita, R. Kiessling, and K. Le Blanc. 2011. The impact of inflammatory licensing on heme oxygenase-1- mediated induction of regulatory T cells by human mesenchymal stem cells. Blood 117: 4826-4835.
27. Meisel, R., A. Zibert, M. Laryea, U. Göbel, W. Däubener, and D. Dilloo. 2004. Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation. Blood 103: 4619-4621. (Pubitemid 38745993)
28. Engelhardt, B. 2008. Immune cell entry into the central nervous system: involvement of adhesion molecules and chemokines. J. Neurol. Sci. 274: 23-26.
29. Constantin, G., S. Marconi, B. Rossi, S. Angiari, L. Calderan, E. Anghileri, B. Gini, S. D. Bach, M. Martinello, F. Bifari, et al. 2009. Adipose-derived mesenchymal stem cells ameliorate chronic experimental autoimmune encephalomyelitis. Stem Cells 27: 2624-2635.
30. Pierantozzi, E., B. Gava, I. Manini, F. Roviello, G. Marotta, M. Chiavarelli, and V. Sorrentino. 2011. Pluripotency regulators in human mesenchymal stem cells: expression of NANOGbut not of OCT-4 and SOX-2. Stem Cells Dev. 20: 915-923.
31. Guo, Z., H. Li, X. Li, X. Yu, H. Wang, P. Tang, and N. Mao. 2006. In vitro characteristics and in vivo immunosuppressive activity of compact bone-derived murine mesenchymal progenitor cells. Stem Cells 24: 992-1000. (Pubitemid 44464732)
32. Linington, C., M. Bradl, H. Lassmann, C. Brunner, and K. Vass. 1988. Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/ oligodendrocyte glycoprotein. Am. J. Pathol. 130: 443-454. (Pubitemid 18091372)
33. Chan, J., E. J. Ban, K. H. Chun, S. Wang, J. McQualter, C. Bernard, B. H. Toh, and F. Alderuccio. 2008. Methylprednisolone induces reversible clinical and pathological remission and loss of lymphocyte reactivity to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis. Autoimmunity 41: 405-413. (Pubitemid 351891202)
34. Zhang, G. X., S. Yu, B. Gran, and A. Rostami. 2005. Glucosamine abrogates the acute phase of experimental autoimmune encephalomyelitis by induction of Th2 response. J. Immunol. 175: 7202-7208. (Pubitemid 41713414)
35. Zepp, J., L. Wu, and X. Li. 2011. IL-17 receptor signaling and T helper 17- mediated autoimmune demyelinating disease. Trends Immunol. 32: 232-239.
36. Duffy, M. M., J. Pindjakova, S. A. Hanley, C. McCarthy, G. A. Weidhofer, E. M. Sweeney, K. English, G. Shaw, J. M. Murphy, F. P. Barry, et al. 2011. Mesenchymal stem cell inhibition of T-helper 17 cell- differentiation is triggered by cell-cell contact and mediated by prostaglandin E2 via the EP4 receptor. Eur. J. Immunol. 41: 2840-2851.
37. Tatara, R., K. Ozaki, Y. Kikuchi, K. Hatanaka, I. Oh, A. Meguro, H. Matsu, K. Sato, and K. Ozawa. 2011. Mesenchymal stromal cells inhibit Th17 but not regulatory T-cell differentiation. Cytotherapy 13: 686-694.
38. Rafei, M., P. M. Campeau, A. Aguilar-Mahecha, M. Buchanan, P. Williams, E. Birman, S. Yuan, Y. K. Young, M. N. Boivin, K. Forner, et al. 2009. Mesenchymal stromal cells ameliorate experimental autoimmune encephalomyelitis by inhibiting CD4 Th17 T cells in a CC chemokine ligand 2-dependent manner. J. Immunol. 182: 5994-6002.
39. Sun, S., Z. Guo, X. Xiao, B. Liu, X. Liu, P. H. Tang, and N. Mao. 2003. Isolation of mouse marrow mesenchymal progenitors by a novel and reliable method. Stem Cells 21: 527-535. (Pubitemid 37444109)
40. Ortiz, L. A., M. Dutreil, C. Fattman, A. C. Pandey, G. Torres, K. Go, and D. G. Phinney. 2007. Interleukin 1 receptor antagonist mediates the anti-inflammatory and antifibrotic effect of mesenchymal stem cells during lung injury. Proc. Natl. Acad. Sci. USA 104: 11002-11007. (Pubitemid 47175216)
41. Bresnihan, B., J. M. Alvaro-Gracia, M. Cobby, M. Doherty, Z. Domljan, P. Emery, G. Nuki, K. Pavelka, R. Rau, B. Rozman, et al. 1998. Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist. Arthritis Rheum. 41: 2196-2204. (Pubitemid 29009378)
42. Wilson, C. A., C. Jacobs, P. Baker, D. G. Baskin, S. Dower, A. Lernmark, B. Toivola, S. Vertrees, and D. Wilson. 1990. IL-1 beta modulation of spontaneous autoimmune diabetes and thyroiditis in the BB rat. J. Immunol. 144: 3784-3788. (Pubitemid 20171186)
43. Jacobs, C. A., P. E. Baker, E. R. Roux, K. S. Picha, B. Toivola, S. Waugh, and M. K. Kennedy. 1991. Experimental autoimmune encephalomyelitis is exacerbated by IL-1 alpha and suppressed by soluble IL-1 receptor. J. Immunol. 146: 2983-2989.
44. Furlan, R., G. Martino, F. Galbiati, P. L. Poliani, S. Smiroldo, A. Bergami, G. Desina, G. Comi, R. Flavell, M. S. Su, and L. Adorini. 1999. Caspase-1 regulates the inflammatory process leading to autoimmune demyelination. J. Immunol. 163: 2403-2409. (Pubitemid 29399158)
45. Sutton, C., C. Brereton, B. Keogh, K. H. Mills, and E. C. Lavelle. 2006. A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis. J. Exp. Med. 203: 1685-1691. (Pubitemid 44036274)
46. Sutton, C. E., S. J. Lalor, C. M. Sweeney, C. F. Brereton, E. C. Lavelle, and K. H. Mills. 2009. Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity. Immunity 31: 331-341.
47. Shrikant, P., I. Y. Chung, M. E. Ballestas, and E. N. Benveniste. 1994. Regulation of intercellular adhesion molecule-1 gene expression by tumor necrosis factoralpha, interleukin-1 beta, and interferon-gamma in astrocytes. J. Neuroimmunol. 51: 209-220. (Pubitemid 24147488)
48. Bullard, D. C., X. Hu, T. R. Schoeb, R. G. Collins, A. L. Beaudet, and S. R. Barnum. 2007. Intercellular adhesion molecule-1 expression is required on multiple cell types for the development of experimental autoimmune encephalomyelitis. J. Immunol. 178: 851-857. (Pubitemid 46095157)
49. Comabella, M., E. Julià, M. Tintoré, L. Brieva, N. Téllez, J. Río, C. López, A. Rovira, and X. Montalban. 2008. Induction of serum soluble tumor necrosis factor receptor II (sTNF-RII) and interleukin-1 receptor antagonist (IL-1ra) by interferon beta-1b in patients with progressive multiple sclerosis. J. Neurol. 255: 1136-1141.
50. Burger, D., N. Molnarfi, M. S. Weber, K. J. Brandt, M. Benkhoucha, L. Gruaz, M. Chofflon, S. S. Zamvil, and P. H. Lalive. 2009. Glatiramer acetate increases IL-1 receptor antagonist but decreases T cell-induced IL-1beta in human monocytes and multiple sclerosis. Proc. Natl. Acad. Sci. USA 106: 4355-4359.
51. Hur, W., M. L. Cho, S. K. Yoon, S. Y. Kim, J. H. Ju, J. Y. Jhun, S. B. Heo, Y. M. Moon, S. Y. Min, S. H. Park, and H. Y. Kim. 2006. Adenoviral delivery of IL-1 receptor antagonist abrogates disease activity during the development of autoimmune arthritis in IL-1 receptor antagonist-deficient mice. Immunol. Lett. 106: 154-162. (Pubitemid 44223744)
52. Furlan, R., A. Bergami, E. Brambilla, E. Butti, M. G. De Simoni, M. Campagnoli, P. Marconi, G. Comi, and G. Martino. 2007. HSV-1-mediated IL-1 receptor antagonist gene therapy ameliorates MOG(35-55)-induced experimental autoimmune encephalomyelitis in C57BL/6 mice. Gene Ther. 14: 93-98. (Pubitemid 44942870)
53. Martin, D., and S. L. Near. 1995. Protective effect of the interleukin-1 receptor antagonist (IL-1ra) on experimental allergic encephalomyelitis in rats. J. Neuroimmunol. 61: 241-245.
54. Bettelli, E., M. P. Das, E. D. Howard, H. L. Weiner, R. A. Sobel, and V. K. Kuchroo. 1998. IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice. J. Immunol. 161: 3299-3306.
55. Esaki, Y., Y. Li, D. Sakata, C. Yao, E. Segi-Nishida, T. Matsuoka, K. Fukuda, and S. Narumiya. 2010. Dual roles of PGE2-EP4 signaling in mouse experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. USA 107: 12233-12238.
56. Harris, S. G., J. Padilla, L. Koumas, D. Ray, and R. P. Phipps. 2002. Prostaglandins as modulators of immunity. Trends Immunol. 23: 144-150. (Pubitemid 34178297)
57. Woolard, M. D., J. E. Wilson, L. L. Hensley, L. A. Jania, T. H. Kawula, J. R. Drake, and J. A. Frelinger. 2007. Francisella tularensis-infected macrophages release prostaglandin E2 that blocks T cell proliferation and promotes a Th2-like response. J. Immunol. 178: 2065-2074. (Pubitemid 46233403)
58. Matysiak, M., W. Orlowski, M. Fortak-Michalska, A. Jurewicz, and K. Selmaj. 2011. Immunoregulatory function of bone marrow mesenchymal stem cells in EAE depends on their differentiation state and secretion of PGE2. J. Neuroimmunol. 233: 106-111.